Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 6
2011 2
2012 3
2013 3
2014 3
2015 1
2016 4
2017 2
2018 5
2019 7
2020 6
2021 8
2022 7
2023 9
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Preeclampsia up to date-What's going on?
Bokuda K, Ichihara A. Bokuda K, et al. Hypertens Res. 2023 Aug;46(8):1900-1907. doi: 10.1038/s41440-023-01323-w. Epub 2023 Jun 2. Hypertens Res. 2023. PMID: 37268721 Free PMC article. Review.
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Free PMC article. Clinical Trial.
2023 update and perspectives.
Mogi M, Tanaka A, Node K, Tomitani N, Hoshide S, Narita K, Nozato Y, Katsurada K, Maruhashi T, Higashi Y, Matsumoto C, Bokuda K, Yoshida Y, Shibata H, Toba A, Masuda T, Nagata D, Nagai M, Shinohara K, Kitada K, Kuwabara M, Kodama T, Kario K. Mogi M, et al. Among authors: bokuda k. Hypertens Res. 2024 Jan;47(1):6-32. doi: 10.1038/s41440-023-01398-5. Epub 2023 Sep 15. Hypertens Res. 2024. PMID: 37710033 Review.
Annual reports on hypertension research 2020.
Mogi M, Higashi Y, Bokuda K, Ichihara A, Nagata D, Tanaka A, Node K, Nozato Y, Yamamoto K, Sugimoto K, Shibata H, Hoshide S, Nishizawa H, Kario K. Mogi M, et al. Among authors: bokuda k. Hypertens Res. 2022 Jan;45(1):15-31. doi: 10.1038/s41440-021-00766-3. Epub 2021 Oct 15. Hypertens Res. 2022. PMID: 34650193 Review.
Update on Hypertension Research in 2021.
Mogi M, Maruhashi T, Higashi Y, Masuda T, Nagata D, Nagai M, Bokuda K, Ichihara A, Nozato Y, Toba A, Narita K, Hoshide S, Tanaka A, Node K, Yoshida Y, Shibata H, Katsurada K, Kuwabara M, Kodama T, Shinohara K, Kario K. Mogi M, et al. Among authors: bokuda k. Hypertens Res. 2022 Aug;45(8):1276-1297. doi: 10.1038/s41440-022-00967-4. Epub 2022 Jul 5. Hypertens Res. 2022. PMID: 35790879 Free PMC article. Review.
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Diagnostic utility of Gold Coast criteria for amyotrophic lateral sclerosis in Asia.
Otani R, Shibuya K, Shimizu T, Kitaoji T, Noto YI, Bokuda K, Kimura H, Suichi T, Nakamura K, Kano H, Morooka M, Aotsuka Y, Ogushi M, Misawa S, Kuwabara S. Otani R, et al. Among authors: bokuda k. Amyotroph Lateral Scler Frontotemporal Degener. 2024 May;25(3-4):264-270. doi: 10.1080/21678421.2024.2303062. Epub 2024 Jan 16. Amyotroph Lateral Scler Frontotemporal Degener. 2024. PMID: 38226616
Solving preeclampsia from SNP in IGFBP-1 gene.
Bokuda K. Bokuda K. Hypertens Res. 2023 Oct;46(10):2430-2432. doi: 10.1038/s41440-023-01410-y. Epub 2023 Aug 15. Hypertens Res. 2023. PMID: 37582849 No abstract available.
67 results